Serological assays are still considered the most useful tests in the diagnosis of syphilis. Since no single serological assay is able to provide a satisfactory result, in our laboratory we have evaluated the usefulness of a commercially-available immunoblot to diagnose syphilis infection among blood donors. From October 2012 to June 2013, 4572 blood donors were screened for syphilis with an automated chemiluminescent microparticle immunoassay (CMIA). To confirm the presence of treponemal antibodies, CMIA-reactive sera were tested by standard Treponema pallidum haemagglutination assay (TPHA). In addition, an alternative confirmatory test – the immunoblot INNO-LIA assay was introduced in our laboratory. Since two additional positives among CMIA-reactive-TPHA-negative samples were found, we concluded that the INNO-LIA immunoblot allowed a better detection of syphilis compared to TPHA. A confirmatory strategy based on the use of two treponemal assays could meet the screening requirements for blood donors as well as in our centre.
LozanoRNaghaviMForemanK. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet2012; 380: 2095–2128.
2.
SalfaMCRegineVFerriM. la Rete Sentinella dei Centri Clinici e dei Laboratori di microbiologia clinica per le Infezioni Sessualmente Trasmesse. [Sexually transmitted diseases: data from the two active sentinel surveillance systems in Italy]. Not Ist Sup Sanità2014; 27: 4–39.
PattonMESuJRNelsonR. Primary and secondary syphilis – United States, 2005–2013. MMWR Morb Mortal Wkly Rep2014; 63: 402–406.
5.
SeñaACWhiteBLSparlingPF. Novel Treponema pallidum serologic tests: a paradigm shift in syphilis screening for the 21st century. Clin Infect Dis2010; 51: 700–708.
6.
SommeseLDe PascaleMRCapuanoM. Efforts in blood safety: integrated approach for serological diagnosis of syphilis. Asian J Transfus Sci2016; 10: 22–30.
7.
DlaminiNRPhiliRConnollyC. Evaluation of rapid syphilis tests in KwaZulu-Natal. J Clin Lab Anal2014; 28: 77–81.
8.
SambriVMarangoniAEyerC. Western Immunoblotting with five Treponema pallidum recombinant antigens for serologic diagnosis of syphilis. Clin Diagn Lab Immunol2001; 8: 534–549.
9.
YoungHPrydeJDuncanL. The architect syphilis assay for antibodies to Treponema pallidum: an automated screening assay with high sensitivity in primary syphilis. Sex Transm Infect2009; 85: 19–23.
10.
MaplePARatcliffeDSmitE. Characterization of Treponema pallidum particle agglutination assay-negative sera following screening by treponemal total antibody enzyme immunoassays. Clin Vaccine Immunol2010; 17: 1718–1722.
11.
SommeseLIannoneCCacciatoreF. Comparison between screening and confirmatory serological assays in blood donors in a region of South Italy. J Clin Lab Anal2014; 2: 198–203.
WellinghausenNDietenbergerH. Evaluation of two automated chemiluminescence immunoassays, the LIAISON Treponema Screen and the ARCHITECT Syphilis TP, and the Treponema pallidum particle agglutination test for laboratory diagnosis of syphilis. Clin Chem Lab Med2011; 49: 1375–1377.
14.
RadolfJDBolanGChowJM. Discordant results from reverse sequence syphilis screening-five laboratories, United States, 2006–2010. MMWR Morb Mortal Wkly Rep2011; 60: 133–137.
15.
LoeffelholzMJBinnickerMJ. It is time to use treponema-specific antibody screening tests for diagnosis of syphilis. J Clin Microbiol2012; 50: 2–6.
16.
FrenchPGombergMJanierM. IUSTI: 2008 European guidelines on the management of syphilis. Int J STD AIDS2009; 20: 300–309.
17.
ChoiSJParkYLeeEY. Comparisons of fully automated syphilis tests with conventional VDRL and FTA-ABS tests. Clin Biochem2013; 46: 834–837.
18.
AktasGYoungHMoyesA. Evaluation of the fluorescent treponemal antibody absorption test for detection of antibodies (immunoglobulins G and M) to Treponema pallidum in serologic diagnosis of syphilis. Int J STD AIDS2007; 18: 255–260.
19.
SatoNSSuzukiTUedaT. Recombinant antigen-based immuno-slot blot method for serodiagnosis of syphilis. Braz J Med Biol Res2004; 37: 949–955.
20.
BinnickerMJJespersenDJRollinsLO. Treponema-specific tests for serodiagnosis of syphilis: comparative evaluation of seven assays. J Clin Microbiol2011; 49: 1313–1317.
21.
WelchRJLitwinC. Evaluation of two immunoblot assays and a Western blot assay for the detection of antisyphilis immunoglobulin g antibodies. Clin Vaccine Immunol2010; 17: 183–184.
22.
EbelAVannesteLCardinaelsM. Validation of the INNO-LIA syphilis kit as a confirmatory assay for Treponema pallidum antibodies. J Clin Microbiol2000; 38: 215–219.
23.
HagedornHJKraminer-HagedornADe BosschereK. Evaluation of INNO-LIA syphilis assay as a confirmatory test for syphilis. J Clin Microbiol2002; 40: 973–978.
24.
JostHCastroACoxD. A comparison of the analytical level of agreement of nine treponemal assays for syphilis and possible implications for screening algorithms. BMJ Open2013; 3: e003347–e003347.
25.
LamTKLauHYLeeYP. Comparative evaluation of the INNO-LIA syphilis score and the MarDx Treponema pallidum immunoglobulin G Marblot test assays for the serological diagnosis of syphilis. Int J STD AIDS2010; 21: 110–113.
26.
LeeKParkHRohEY. Characterization of sera with discordant results from reverse sequence screening for syphilis. Biomed Res Int2013; 2013: 269347–269347.
27.
LamTKLauHYLeeYP. Use of the INNO-LIA syphilis score assay in the resolution of discordant positive screening enzyme immunoassay results for the serological diagnosis of syphilis. Int J STD AIDS2014; 25: 52–56.
28.
de LemosEABelémZRSantosA. Characterization of the Western blotting IgG reactivity patterns in the clinical phases of acquired syphilis. Diagn Microbiol Infect Dis2007; 58: 177–183.
29.
SunRLaiDHRenRX. Treponema pallidum-specific antibody expression for the diagnosis of different stages of syphilis. Chin Med J (Engl)2013; 126: 206–210.
30.
WorkowskiKABermanS. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2010. MMWR Morb Mortal Wkly Rep2010; 59: 1–110.
31.
TongMLLinLRLiuLL. Analysis of 3 algorithms for syphilis serodiagnosis and implications for clinical management. Clin Infect Dis2014; 58: 1116–1124.
